BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15064494)

  • 1. TP53 mutation detection by SSCP and sequencing.
    Hakkarainen J; Welsh JA; Vähäkangas KH
    Methods Mol Med; 2004; 97():191-208. PubMed ID: 15064494
    [No Abstract]   [Full Text] [Related]  

  • 2. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
    Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
    Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of p53 in human tumors: direct DNA sequencing and SSCP.
    Erster S; Slade N; Moll UM
    Methods Mol Biol; 2003; 234():219-30. PubMed ID: 12824535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of TP53 gene mutations in human lung cancer: comparison of capillary electrophoresis single strand conformation polymorphism assay with denaturing gradient gel electrophoresis and direct sequencing.
    Holmila R; Husgafvel-Pursiainen K
    Cancer Detect Prev; 2006; 30(1):1-6. PubMed ID: 16458448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [p53 gene mutation determined by single-strand conformational polymorphism and DNA sequencing analysis in pleomorphic adenoma of salivary gland].
    Wang J; Dong F; Yong P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):298-300. PubMed ID: 11776898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSCP/heteroduplex analysis.
    Wallace AJ
    Methods Mol Biol; 2002; 187():151-63. PubMed ID: 12013742
    [No Abstract]   [Full Text] [Related]  

  • 7. An optimized microchip electrophoresis system for mutation detection by tandem SSCP and heteroduplex analysis for p53 gene exons 5-9.
    Hestekin CN; Jakupciak JP; Chiesl TN; Kan CW; O'Connell CD; Barron AE
    Electrophoresis; 2006 Oct; 27(19):3823-35. PubMed ID: 16972304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
    Fukuda M; Nakatsuka T; Kusama K; Sakashita H
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficient mutation detection in MEN1 gene using a combination of single-strand conformation polymorphism (MDGA) and heteroduplex analysis.
    Crépin M; Escande F; Pigny P; Buisine MP; Calender A; Porchet N; Odou MF;
    Electrophoresis; 2003 Jan; 24(1-2):26-33. PubMed ID: 12652570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated method for mutation detection using on-chip sample preparation, single-stranded conformation polymorphism, and heteroduplex analysis.
    Vahedi G; Kaler K; Backhouse CJ
    Electrophoresis; 2004 Jul; 25(14):2346-56. PubMed ID: 15274017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intronic variant in the TP53 gene in a Brazilian woman with breast cancer.
    Lacerda LL; Serrano SV; Mathes A; Rey JA; Bello MJ; Casartelli C
    Cancer Genet Cytogenet; 2005 Jul; 160(2):160-3. PubMed ID: 15993272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
    Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
    J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of TP53-DNA interaction induced by p.C135R in lung cancer.
    Aranda M; Gonzalez-Nilo F; Riadi G; Díaz V; Perez J; Martel G; Hainaut P; Mimbacas A
    Oncol Rep; 2007 Nov; 18(5):1213-7. PubMed ID: 17914575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single temperature endonuclease-enhanced single-strand conformation polymorphism/heteroduplex mutation analysis: evaluation of the method.
    Hofman-Bang J; Christiansen M
    Scand J Clin Lab Invest; 2004; 64(6):605-7. PubMed ID: 15370467
    [No Abstract]   [Full Text] [Related]  

  • 16. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis.
    Yanagisawa N; Yamashita K; Kuba T; Okayasu I
    Anticancer Res; 2010 Nov; 30(11):4443-9. PubMed ID: 21115891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular diagnosis of cancer by non-radioisotopic PCR/SSCP analysis].
    Sugano K
    Tanpakushitsu Kakusan Koso; 1996 Apr; 41(5):638-42. PubMed ID: 8650356
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of DNA aberrations in human cancers by AP-PCR-SSCP analysis].
    Okano A; Sekiya T
    Tanpakushitsu Kakusan Koso; 1996 Apr; 41(5):633-7. PubMed ID: 8650355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.